One-year follow-up of patients with severe tricuspid regurgitation: prognostic impact of right heart failure staging

Read full text
Authors: Juan Carlos Gómez Polo, Itzíar Gómez, Patricia Mahía Casado, Esther Pérez David, Pere Pericàs, José Antonio Parada Barcía, Carlos Eduardo Izurieta, Ana Revilla-Orodea, Vanessa Moñivas, Ana Testa, Lara Miguel, Irene Carrión Sánchez
+42 more Laura Gutiérrez, José Ramón Ortega Trujillo, Nuria Hernández Vicente, Lucía Torres Quintero, Olatz Zaldua Irastorza, Mónica Delgado Ortega, Ana Osa Sáez, María Victoria Millán, María de los Ángeles Pérez, Almudena Aguilera, Isaac Pascual, I Mendez, Marc Abulí Lluch, Teresa Delgado, Ariana González Gómez, Samuel del Castillo, Pilar Martín de la Fuente, Pedro Morillas, Daniel Gaitán Román, María Victoria Mogollón, Ana Payá Chaume, Alberto Bouzas, Jana Pérez, J Tolosa Sanchez, Ángel López Cuenca, Elvis Amao, José Carlos Fernández Camacho, Teresa Blasco‐Peiró, Ildefonso Roldán, Catherine Graupner, Carmen Manzano, Amparo Martínez Monzonís, Alex Ruiz Majoral, Luca Vannini, Mario Baquero Alonso, Lizandro Rodríguez, Fernando Cabrera, Marı́a Jesús Rollán, Raúl Reyes, Cristina Fernández Pérez, J. Alberto San Román, Isidre Vilacosta
Cited by: 0
References: 24

Abstract

INTRODUCTION: Severe tricuspid regurgitation (STR) is associated with adverse outcomes. This nationwide registry describes the prevalence, aetiology, clinical, and echocardiographic profile of STR using contemporary classifications, and evaluates the prognostic impact of a modified right heart failure staging (RHFS). METHODS: We prospectively enrolled consecutive patients with STR from 48 centres over 6 months and followed them for 1 year. TR severity (severe, massive, torrential) and aetiology were defined using current recommendations. A modified RHFS incorporating RV remodelling and systolic dysfunction was applied. RESULTS: We included 1247 patients (mean age 76.7 ± 10.5 years; 70.2% women): 64.9% had severe TR, 24.1% massive TR, and 11.0% torrential TR. V-STR due to left-heart disease was the most frequent aetiology (49.9%), followed by A-STR (19.8%). During follow-up, HF hospitalization occurred in 20.8%, cardiovascular death in 9.2%, and 12.3% underwent tricuspid intervention. In multivariable analysis, Stages III-IV of the modified RHFS were independently associated with HF hospitalization (HR 1.58; 95% CI 1.13-2.23; P = .008) and cardiovascular mortality (HR 2.01; 95% CI 1.27-3.18; P = .003). Massive (HR 1.72; 95% CI 1.02-2.91; P = .041) and torrential TR (HR 2.57; 95% CI 1.24-5.34; P = .011) were also associated with cardiovascular mortality. CONCLUSION: Massive and torrential TR identify patients at the highest risk. The modified RHFS stratifies patients with STR into prognostic categories and may help guide the timing of intervention.

Fields of Study & Subjects

Cardiac Valve Diseases and Treatments Cardiovascular Function and Risk Factors Aortic Disease and Treatment Approaches

Publication details

Journal / source
ESC Heart Failure
Volume
13
Issue
1
Publication date
14 January 2026
Language
EN